Xin-Chun Ye1, Jin-Xia Hu1, Lei Li1, Qiang Li1, Fu-Lei Tang1, Sen Lin1, Dong Sun1, Xiang-Dong Sun1, Gui-Yun Cui1, Lin Mei1, Wen-Cheng Xiong2. 1. From the Department of Neuroscience and Regenerative Medicine (X.-C.Y., J.-X.H., L.L., Q.L., F.-L.T., S.L., D.S., X.-D.S., L.M., W.-C.X.) and Department of Neurology (X.-C.Y., J.-X.H., L.L., Q.L., F.-L.T., S.L., D.S., X.-D.S., L.M., W.-C.X.), Medical College of Georgia, Augusta University; Institute of Nervous System Diseases (X.-C.Y., J.-X.H.) and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University (X.-C.Y., J.-X.H., G.-Y.C.), Xuzhou Medical University, Jiangsu, China; and Department of Hand Surgery, China Japan Union Hospital, Jilin University, Changchun (Q.L.). 2. From the Department of Neuroscience and Regenerative Medicine (X.-C.Y., J.-X.H., L.L., Q.L., F.-L.T., S.L., D.S., X.-D.S., L.M., W.-C.X.) and Department of Neurology (X.-C.Y., J.-X.H., L.L., Q.L., F.-L.T., S.L., D.S., X.-D.S., L.M., W.-C.X.), Medical College of Georgia, Augusta University; Institute of Nervous System Diseases (X.-C.Y., J.-X.H.) and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University (X.-C.Y., J.-X.H., G.-Y.C.), Xuzhou Medical University, Jiangsu, China; and Department of Hand Surgery, China Japan Union Hospital, Jilin University, Changchun (Q.L.). wxiong@augusta.edu.
Abstract
BACKGROUND AND PURPOSE: Lrp4 (low-density lipoprotein receptor-related protein 4) is predominantly expressed in astrocytes, where it regulates glutamatergic neurotransmission by suppressing ATP release. Here, we investigated Lrp4's function in ischemia/stroke-induced brain injury response, which includes glutamate-induced neuronal death and reactive astrogliosis. METHODS: The brain-specific Lrp4 conditional knockout mice (Lrp4GFAP-Cre), astrocytic-specific Lrp4 conditional knockout mice (Lrp4GFAP-creER), and their control mice (Lrp4f/f) were subjected to photothrombotic ischemia and the transient middle cerebral artery occlusion. After ischemia/stroke, mice or their brain samples were subjected to behavior tests, brain histology, immunofluorescence staining, Western blot, and quantitative real-time polymerase chain reaction. In addition, primary astrocytes and neurons were cocultured with or without oxygen and glucose deprivation and in the presence or absence of the antagonist for adenosine-A2AR (adenosine A2A receptor) or ATP-P2X7R (P2X purinoceptor 7) signaling. Gliotransmitters, such as glutamate, d-serine, ATP, and adenosine, in the condition medium of cultured astrocytes were also measured. RESULTS: Lrp4, largely expressed in astrocytes, was increased in response to ischemia/stroke. Both Lrp4GFAP-Cre and Lrp4GFAP-creER mice showed less brain injury, including reduced neuronal death, and impaired reactive astrogliosis. Mechanistically, Lrp4 conditional knockout in astrocytes increased ATP release and the production of ATP derivative, adenosine, which were further elevated by oxygen and glucose deprivation. Pharmacological inhibition of ATP-P2X7R or adenosine-A2AR signaling diminished Lrp4GFAP-creER's protective effect. CONCLUSIONS: The astrocytic Lrp4 plays an important role in ischemic brain injury response. Lrp4 deficiency in astrocytes seems to be protective in response to ischemic brain injury, likely because of the increased ATP release and adenosine-A2AR signaling.
BACKGROUND AND PURPOSE:Lrp4 (low-density lipoprotein receptor-related protein 4) is predominantly expressed in astrocytes, where it regulates glutamatergic neurotransmission by suppressing ATP release. Here, we investigated Lrp4's function in ischemia/stroke-induced brain injury response, which includes glutamate-induced neuronal death and reactive astrogliosis. METHODS: The brain-specific Lrp4 conditional knockout mice (Lrp4GFAP-Cre), astrocytic-specific Lrp4 conditional knockout mice (Lrp4GFAP-creER), and their control mice (Lrp4f/f) were subjected to photothrombotic ischemia and the transient middle cerebral artery occlusion. After ischemia/stroke, mice or their brain samples were subjected to behavior tests, brain histology, immunofluorescence staining, Western blot, and quantitative real-time polymerase chain reaction. In addition, primary astrocytes and neurons were cocultured with or without oxygen and glucose deprivation and in the presence or absence of the antagonist for adenosine-A2AR (adenosine A2A receptor) or ATP-P2X7R (P2X purinoceptor 7) signaling. Gliotransmitters, such as glutamate, d-serine, ATP, and adenosine, in the condition medium of cultured astrocytes were also measured. RESULTS:Lrp4, largely expressed in astrocytes, was increased in response to ischemia/stroke. Both Lrp4GFAP-Cre and Lrp4GFAP-creER mice showed less brain injury, including reduced neuronal death, and impaired reactive astrogliosis. Mechanistically, Lrp4 conditional knockout in astrocytes increased ATP release and the production of ATP derivative, adenosine, which were further elevated by oxygen and glucose deprivation. Pharmacological inhibition of ATP-P2X7R or adenosine-A2AR signaling diminished Lrp4GFAP-creER's protective effect. CONCLUSIONS: The astrocytic Lrp4 plays an important role in ischemic brain injury response. Lrp4 deficiency in astrocytes seems to be protective in response to ischemic brain injury, likely because of the increased ATP release and adenosine-A2AR signaling.
Authors: Igor Fijalkowski; Ellen Geets; Ellen Steenackers; Viviane Van Hoof; Feliciano J Ramos; Geert Mortier; Ana Maria Fortuna; Wim Van Hul; Eveline Boudin Journal: J Bone Miner Res Date: 2016-01-24 Impact factor: 6.741
Authors: Anna G Orr; Edward C Hsiao; Max M Wang; Kaitlyn Ho; Daniel H Kim; Xin Wang; Weikun Guo; Jing Kang; Gui-Qiu Yu; Anthony Adame; Nino Devidze; Dena B Dubal; Eliezer Masliah; Bruce R Conklin; Lennart Mucke Journal: Nat Neurosci Date: 2015-01-26 Impact factor: 24.884
Authors: Marta Carmo; Francisco Q Gonçalves; Paula M Canas; Jean-Pierre Oses; Francisco D Fernandes; Filipe V Duarte; Carlos M Palmeira; Angelo R Tomé; Paula Agostinho; Geanne M Andrade; Rodrigo A Cunha Journal: Br J Pharmacol Date: 2019-08-01 Impact factor: 8.739
Authors: R Brito; K C Calaza; D Pereira-Figueiredo; A A Nascimento; M C Cunha-Rodrigues Journal: Cell Mol Neurobiol Date: 2021-03-17 Impact factor: 5.046
Authors: Liliana Dias; Cátia R Lopes; Francisco Q Gonçalves; Ana Nunes; Daniela Pochmann; Nuno J Machado; Angelo R Tomé; Paula Agostinho; Rodrigo A Cunha Journal: Front Cell Neurosci Date: 2021-03-01 Impact factor: 5.505